Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2017 | GenXComm | $7.0M Series A | Dan Artusi | Matrix, Walden International, Lip-Bu Tan, Azure Capital Partners, Bandgap Ventures, Capital Factory, FAM Capital Partners, Nick Tulloh, WS Investments |
| Jun 7, 2017 | Lung Therapeutics | $14.3M Series B | Aaron Fletcher | — |
| Aug 9, 2016 | Alafair Biosciences | $2.0M Series A | Kyle Cox | — |
| Mar 1, 2015 | Aeglea BioTherapeutics | $44.0M Series B | Armen Shanafelt, Novartis | RA Capital, Ally Bridge Group, Cowen Healthcare Investments, Jennison Associates, OrbiMed, Rajeev Shah, Rock Springs Capital, Venrock |